Metabolic, Diabetes Landscape “Fertile Ground” For Partnerships
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharma should look at market that “grows larger with every meal,” says Healogix CEO Kaplan.
You may also be interested in...
Orexigen Starts Partnership Talks On Obesity Drug Contrave
Firm stresses Phase III efficacy results will pass muster with FDA.
Orexigen Starts Partnership Talks On Obesity Drug Contrave
Firm stresses Phase III efficacy results will pass muster with FDA.
Wyeth Re-enters Appetite Suppression Game With Thiakis Acquisition
Metabolic disorders is one of six focus areas targeted by Wyeth’s new discovery plan.